Answers are grounded in this paper and cite their sources.
Introduction: Human papillomavirus (HPV) is widely recognized as a contributing factor in the etiopathogenesis of squamous cell carcinoma affecting the oral cavity and oropharyngeal regions. The present study was designed to assess the presence of active HPV infection in oral and oropharyngeal malignancies through immunohistochemically evaluation using the P16 biomarker. Methods: This laboratory-based analytical cross-sectional study investigated P16 protein expression via immunohistochemistry on paraffin-embedded tissue blocks retrieved from 35 cases diagnosed with oral and oropharyngeal squamous cell carcinoma who had no history of smoking or alcohol consumption. The samples were obtained from the archives of the School of Dentistry and Shahid Sadoughi Hospital in Yazd City between 1999 and 2019. Data were analyzed using descriptive statistical methods alongside the chi-square test via SPSS software version 18. Results: In this descriptive study, a total of 35 tissue samples obtained from patients diagnosed with oral cavity and oropharyngeal carcinoma were examined. The most common site of involvement was the tongue (57.1%), and the most common histological grade was well differentiated (57.1%). Regarding the clinical staging, the majority of the patients presented with stage II disease (34.3%). A statistically significant difference was found between males and females regarding the site of tumor involvement (P=0.018); specifically, tongue involvement was more common among males, whereas lesions on the lips and oral vestibular were more commonly identified in females. Conversely, no statistically significant associations were found between P16 expression or HPV status and other clinicopathological variables, including age, histological grading, and disease stage. Notably, active HPV infection was not detected in any of the examined samples. Conclusion: In this study, active HPV infection was not detected in oral cavity and oropharyngeal cancer using the P16 marker, and the validity of P16 as a surrogate marker requires further investigation.
No takes yet. Share an insight, caveat, or question.
Tabatabaei et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: